Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome

Hemasphere. 2024 Jul 30;8(8):e129. doi: 10.1002/hem3.129. eCollection 2024 Aug.

Authors

Anna M Aalbers¹, Paul L A van Daele², Virgil A S H Dalm², Peter J M Valk¹, Marc H G P Raaijmakers¹

Affiliations

¹ Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam The Netherlands.
² Department of Internal Medicine, Division of Allergy & Clinical Immunology, and Department of Immunology, Erasmus MC University Medical Center Rotterdam Rotterdam the Netherlands.

No abstract available